Insider Transactions in Q2 2021 at Clovis Oncology, Inc. (CLVS)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 03
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
7
-0.56%
|
$35
$5.63 P/Share
|
Jun 03
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
131
-7.06%
|
$655
$5.63 P/Share
|
Jun 03
2021
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
283
-0.11%
|
$1,415
$5.63 P/Share
|
Jun 03
2021
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
322
-0.44%
|
$1,610
$5.63 P/Share
|
Jun 03
2021
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
231
-0.42%
|
$1,155
$5.63 P/Share
|
Jun 03
2021
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
231
-0.47%
|
$1,155
$5.63 P/Share
|
Jun 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
18
+1.43%
|
-
|
Jun 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
281
+13.15%
|
-
|
Jun 01
2021
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
687
+0.27%
|
-
|
Jun 01
2021
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
687
+0.92%
|
-
|
Jun 01
2021
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
562
+1.0%
|
-
|
Jun 01
2021
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
562
+1.12%
|
-
|
May 04
2021
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
4,838
-3.3%
|
$24,190
$5.54 P/Share
|
May 04
2021
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
4,501
-3.02%
|
$22,505
$5.54 P/Share
|
May 04
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
80
-6.14%
|
$400
$5.54 P/Share
|
May 04
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
1,799
-45.67%
|
$8,995
$5.54 P/Share
|
May 04
2021
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
4,837
-2.93%
|
$24,185
$5.54 P/Share
|
May 04
2021
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
3,952
-0.79%
|
$19,760
$5.54 P/Share
|
May 01
2021
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,248
+6.51%
|
-
|
May 01
2021
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+5.32%
|
-
|
May 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
181
+12.19%
|
-
|
May 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,374
+45.81%
|
-
|
May 01
2021
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,248
+5.83%
|
-
|
May 01
2021
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+1.64%
|
-
|